[3] Harris PNA, Tambyah PA, Lye DC, et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinica...
[3] Harris PNA, Tambyah PA, Lye DC, et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial [published correction appears in JAMA. 2019 Jun 18;321(2...
E. coliEnterobacteriaceaeMortalityIn a previous study, we demonstrated prolonged length of hospital stay in cases of extended-spectrum beta-lactamase (ESBL)-positiveK. pneumoniaebacteremia compared to bacteremia cases due toE. coli(ESBL-positive and –negative) and ESBL-negativeK. pneumoniae. The ...
45744581产ESBLs菌株血行感染:头孢菌素的经验性治疗疗效判断与MIC的相关性Bloodstream Infections Due to Extended-SpectrumBeta-Lactamase-Producing Escherichia coli and Klebsiella pneumo 20、niae:Risk Factors for Mortality and Treatment Outcome, with SpecialEmphasis on Antimicrobial Therapy. AAC. 2004, 48,(12)...
Bloodstream Infections Due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy. AAC. 2004, 48,(12),p. 4574–4581 产ESBLs菌株血行感染:病死率增加的危险因素之一——广谱...
To further understand the role of ST131 in community-onset non-ESBL-producing E. coli bacteremia, we collected non-duplicated consecutive E. coli bloodstream infection isolates in 2010 in a medical center in southern Taiwan. Our goals were to determine the percent- age of ST131 in community-...
E. coli K. pneumoniae 15 学习交流PPT 28.6 45.7 59 54.6 57.8 60 60.2 60.2 61.3 25.7 34.9 47.7 36.6 40.4 51.5 38 45.7 40.6 0 10 20 30 40 50 60 70 200120022003200420052006200720082010 大肠埃希菌 肺炎克雷伯菌 % Wang H, Chen M. Diagnos Microbiol Infect Dis, 2005, 51, 201-208 CMSS/SEAN...
肠杆菌科细菌产ESBLsAll(1651)E.coli(953)Klebsiella(357)EnterobacterCitrobacter,Serratia(175)ESBL+??1617??Imipenem0000Ertapenem0000Cefotaxime14.714.415.425.1Ceftazidime(5.9)(2.7)(8.1)20.0Pip/taz9.57.113.221.7Ciprofloxacin40.850.625.222.9AntimicrobAgentsChemother.Jan;50(1):374-8.产ESBLs肠杆菌科细菌感染的...
epidemiology and risk factors of community onset infections caused by extended-spectrum -lactamase-producing escherichia coli strains. j clin microbiol 2012; 50 38、(2):312-7.5. rodrguez-bao j, picn e, gijn p, et al. community-onset bacteremia due to extended-spectrum beta-lactamase-...
de Kraker ME, Davey PG, Grundmann H: Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011, 8 (10): e1001104-10.1371/journal.pmed.1001104. ...